Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anaemia Response to the Treatment”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)Study completedNCT01701310
What this trial is testing

IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia

Who this might be right for
AnemiaColorectal Neoplasm
Nottingham University Hospitals NHS Trust 116
Not applicableStudy completedNCT03310736
What this trial is testing

Serum Hepcidin Immunoassay - Laboratory to Marketplace

Who this might be right for
Anemia, Iron Deficiency
Intrinsic LifeSciences, LLC 494
Testing effectiveness (Phase 2)Study completedNCT01977482
What this trial is testing

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

Who this might be right for
Anaemia
GlaxoSmithKline 216
Post-approval studies (Phase 4)UnknownNCT02225886
What this trial is testing

Ascorbic Acid Administration in the Treatment of Anemia in Chronic Hemodialysed Patients

Who this might be right for
Anaemia Response to the TreatmentPeripheral Iron IndicesOxalemia
Anemia Working Group Romania 100
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Large-scale testing (Phase 3)Active Not RecruitingNCT00843882
What this trial is testing

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

Who this might be right for
AnemiaChronic Myelomonocytic LeukemiaDe Novo Myelodysplastic Syndrome+1 more
National Cancer Institute (NCI) 247
Testing effectiveness (Phase 2)Study completedNCT01906489
What this trial is testing

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Akebia Therapeutics 210
Post-approval studies (Phase 4)Active Not RecruitingNCT05891249
What this trial is testing

Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

Who this might be right for
Anemia
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Study completedNCT03030183
What this trial is testing

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Ra Pharmaceuticals 3
Post-approval studies (Phase 4)Ended earlyNCT02624141
What this trial is testing

Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Who this might be right for
Anemia
Hoffmann-La Roche 10
Post-approval studies (Phase 4)Study completedNCT00283465
What this trial is testing

The Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Who this might be right for
AnemiaNeoplasm
Janssen-Cilag B.V. 316
Not applicableUnknownNCT01785355
What this trial is testing

The Impact Of Periodontal Disease Treatment On The General Health Status In Chronic Haemodialyzed Patients

Who this might be right for
Periodontal DiseaseChronic Kidney Disease
Anemia Working Group Romania 30
Testing effectiveness (Phase 2)Study completedNCT00086086
What this trial is testing

Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia

Who this might be right for
Congestive Heart FailureAnemia
Amgen 150
Testing effectiveness (Phase 2)Study completedNCT00328549
What this trial is testing

Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)

Who this might be right for
Hepatitis CAnemia
Ortho Biotech Products, L.P. 105
Large-scale testing (Phase 3)Study completedNCT00210587
What this trial is testing

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 51
Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Testing effectiveness (Phase 2)Study completedNCT00388336
What this trial is testing

PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy

Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 57
Post-approval studies (Phase 4)Ended earlyNCT02608060
What this trial is testing

Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Who this might be right for
Anemia
Hoffmann-La Roche 4
Testing effectiveness (Phase 2)Ended earlyNCT05116774
What this trial is testing

BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
BioCryst Pharmaceuticals 12
Not applicableStudy completedNCT01168349
What this trial is testing

An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

Who this might be right for
Anemia, Neoplasms
Hoffmann-La Roche 1,060
Load More Results